Neuropathogenesis of congenital cytomegalovirus infection: Disease mechanisms and prospects for intervention

Clinical Microbiology Reviews

Volumn 22, Issue 1, 2009, Pages 99-126

  Cheeran, Maxim C J ^a   Lokensgard, James R ^a   Schleiss, Mark R ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CIDMTR 3 222 TRF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOMEGALOVIRUS ANTIBODY; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; LIVE VACCINE; VALGANCICLOVIR;

CHILL; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; FEVER; FLUSHING; HEADACHE; HUMAN; INFECTION RISK; LABYRINTHITIS; NEPHROTOXICITY; NEUROPATHOLOGY; NEUTROPENIA; NONHUMAN; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA; VIRUS PATHOGENESIS; CENTRAL NERVOUS SYSTEM DISEASE; FEMALE; IMMUNOLOGY; NEWBORN; PATHOLOGY; PREGNANCY; VIROLOGY;

ANIMALIA; CYTOMEGALOVIRUS;

ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY;

EID: 59649086482     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00023-08     Document Type: Review

References (290)

1. Abbott, N. J., L. Ronnback, and E. Hansson. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7: 41-53.
2. Adler, B., L. Scrivano, Z. Ruzcics, B. Rupp, C. Sinzger, and U. Koszinowski. 2006. Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J. Gen. Virol. 87:2451-2460.
3. Adler, S. P., J. W. Finney, A. M. Manganello, and A. M. Best. 2004. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J. Pediatr. 145:485-491.
4. Adler, S. P., S. H. Hempfling, S. E. Starr, S. A. Plotkin, and S. Riddell. 1998. Safety and immunogenicity of the Towne strain cytomegalovirus vaccine. Pediatr. Infect. Dis. J. 17:200-206.
5. Adler, S. P., and G. Nigro. 2006. Interrupting intrauterine transmission of cytomegalovirus. Rev. Med. Virol. 16:69-71.
6. Adler, S. P., G. Nigro, and L. Pereira. 2007. Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin. Perinatol. 31:10-18.
7. Adler, S. P., S. A. Plotkin, E. Gonczol, M. Cadoz, C. Meric, J. B. Wang, P. Dellamonica, A. M. Best, J. Zahradnik, S. Pincus, K. Berencsi, W. I. Cox, and Z. Gyulai. 1999. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). J. Infect. Dis. 180:843-846.
8. Adler, S. P., S. E. Starr, S. A. Plotkin, S. H. Hempfling, J. Buis, M. L. Manning, and A. M. Best. 1995. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J. Infect. Dis. 171:26-32.
9. Akter, P., C. Cunningham, B. P. McSharry, A. Dolan, C. Addison, D. J. Dargan, A. F. Hassan-Walker, V. C. Emery, P. D. Griffiths, G. W. Wilkinson, and A. J. Davison, 2003. Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84:1117-1122.
10. Anastassova-Kristeva, M. 2003. The origin and development of the immune system with a view to stem cell therapy. J. Hematother. Stem Cell Res. 12:137-154.
11. Ancora, G., M. Lanari, T. Lazzarotto, V. Venturi, E. Tridapalli, F. Sandri, M. Menarini, E. Ferretti, and G. Faldella. 2007. Cranial ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection. J. Pediatr. 150:157-161.
12. Andriesse, G. L, A. J. Weersink, and J. de Boer. 2006. Visual impairment and deafness in young children: consider the diagnosis of congenital infection with cytomegalovirus, even years after birth. Arch. Ophthalmol. 124: 743.
13. Arav-Boger, R., C. A. Battaglia, T. Lazzarotto, L. Gabrielli, J. C. Zong, G. S. Hayward, M. Diener-West, and M. P. Landini. 2006. Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J. Infect. Dis. 194:464-473.
14. Arnoult, D., L. M. Bartle, A. Skaletskaya, D. Poncet, N. Zamzami, P. U. Park, J. Sharpe, R. J. Youle, and V. S. Goldmacher. 2004. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc. Natl. Acad. Sci. USA 101:7988-7993.
15. Ashkenazi, A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2:420-430.
16. Attard-Montalto, S. P., M. C. English, L. Stimmler, and G. J. Snodgrass. 1993. Ganciclovir treatment of congenital cytomegalovirus infection: a report of two cases. Scand. J. Infect. Dis. 25:385-388.
17. Bachor, E, H. Sudhoff, R. Litschel, and C. S. Karmody. 2000. The pathology of the temporal bones of a child with acquired cytomegalovirus infection: studies by light microscopy, immunohistochemistry and polymerase-chain reaction. Int. J. Pediatr. Otorhinolaryngol. 55:215-224.
18. Bakardjiev, A- I., B. A. Stacy, S. J. Fisher, and D. A- Portnoy. 2004. Listeriosis in the pregnant guinea pig: a model of vertical transmission. Infect. Immun. 72:489-497.
19. Bakardjiev, A. I., B. A. Stacy, and D. A. Portnoy. 2005. Growth of Listeria monocytogenes in the guinea pig placenta and role of cell-to-cell spread in fetal infection. J. Infect. Dis. 191:1889-1897.
20. Balfour, H. H., Jr., G. W. Sachs, P. Welo, R. C. Gehrz, R. L. Simmons, and J. S. Najarian. 1984. Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial. Birth Defects Orig. Artic. Ser. 20:289-304.
21. Bantug, G. R., D. Cekinovic, R. Bradford, T. Koontz, S. Jonjic, and W. J. Britt. 2008. CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals. J. Immunol. 181: 2111-2123.
22. Barkovich, A. J., and N. Girard. 2003. Fetal brain infections. Childs Nerv. Syst. 19:501-507.
23. Barkovich, A. J., and C. E. Lindan. 1994. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am. J. Neuroradiol. 15:703-715.
24. Baron, M. H., and S. T. Fraser. 2005. The specification of early hemato-poiesis in the mammal. Curr. Opin. Hematol. 12:217-221.
25. Bass, K. E., H. Li, S. P. Hawkes, E. Howard, E. Bullen, T. K. Vu, M. McMaster, M. Janatpour, and S. J. Fisher. 1997. Tissue inhibitor of met-alloproteinase-3 expression is upregulated during human cytotrophoblast invasion in vitro. Dev. Genet. 21:61-67.
26. Bauer, P. W., M, Parizi-Robinson, P. S. Roland, and S. Yegappan. 2005. Cytomegalovirus in the perilymphatic fluid. Laryngoscope 115:223-225.
27. Benedict, C. A. 2003. Viruses and the TNF-related cytokines, an evolving battle. Cytokine Growth Factor Rev. 14:349-357.
28. Benedict, C. A., P. S. Norris, and C. F. Ware. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3:1013-1018.
29. Bentz, G. L., M. Jarquin-Pardo, G. Chan, M. S. Smith, C. Sinzger, and A. D. Yuroehko. 2006. Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J. Virol. 80:11539-11555.
30. Bernstein, D. I., M. R. Schleiss, K. Berencsi, E. Gonczol, M. Dickey, P. Khoury, M. Cadoz, C. Meric, J. Zahradnik, A. M. Duliege, and S. Plotkin. 2002. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. J. Infect. Dis. 185:686-690.
31. Bia, F. J., B. P. Griffith, M. Tarsio, and G. D. Hsiung. 1980. Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus. J. Infect. Dis. 142:732-738.
32. Bigger, J, E., M. Tanigawa, M. Zhang, and S. S. Atherton. 2000. Murine cytomegalovirus infection causes apoptosis of uninfected retinal cells. In-vestig. Ophthalmol. Vis. Sci. 41:2248-2254.
33. Boppana, S. B., and W. J. Britt. 1995. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J. Infect. Dis. 171:1115-1121.
34. Boppana, S. B., K. B. Fowler, W. J. Britt, S. Stagno, and R. F. Pass. 1999. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104:55-60.
35. Boppana, S. B., K. B. Fowler, R. F. Pass, L. B. Rivera, R. D. Bradford, F. D. Lakeman, and W. J. Britt. 2005. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J. Pediatr. 146:817-823.
36. Boppana, S. B., K. B. Fowler, Y. Vaid, G. Hedlund, S. Stagno, W. J. Britt, and R. F. Pass. 1997. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99:409-414.
37. Boppana, S. B., J. Miller, and W. J. Britt. 1996. Transplacentally acquired antiviral antibodies and outcome in congenital human cytomegalovirus infection. Viral Immunol. 9:211-218.
38. Boppana, S. B., R. F. Pass, and W. J. Britt. 1993. Virus-specific antibody responses in mothers and their newborn infants with asymptomatic congenital cytomegalovirus infections. J. Infect. Dis. 167:72-77.
39. Boppana, S. B., L. B. Rivera, K. B. Fowler, M. Mach, and W. J. Britt. 2001. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344:1366-1371.
40. Bourne, N., M. R. Schleiss, F. J. Bravo, and D. I. Bernstein. 2001. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection. J. Infect. Dis. 183:59-64.
41. Bresnahan, W. A., L Boldogh, E. A, Thompson, and T. Albrecht. 1996. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late Gl. Virology 224:150-160.
42. Britt, W. J. 1996. Human cytomegalovirus infections during pregnancy, p. 327-343, Baillière's clinical infectious diseases, vol. 3. Baillière Tindall. Oxford. United Kingdom.
43. Brune, W., M. Nevels, and T. Shenk. 2003. Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein. J. Virol. 77:11633-11643.
44. Cannon, M, J., and K. F. Davis. 2005. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5:70.
45. Carson, M. J., J. M. Doose, B. Melchior, C. D. Schmid, and C. C. Ploix. 2006. CNS immune privilege: hiding in plain sight. Immunol. Rev. 213: 48-65.
46. Castillo, J. P., and T. F. Kowalik. 2002. Human cytomegalovirus immediate early proteins and cell growth control. Gene 290:19-34.
47. Chaouat, G., N. Ledee-Bataille, and S. Dubanchet. 2007. Immune cells in uteroplacental tissues throughout pregnancy: a brief review. Reprod. Biomed. Online 14:256-266.
48. Cheeran, M. C., G. Gekker, S. Hu, X. Min, D. Cox, and J. R. Lokensgard. 2004. Intracerebral infection with murine cytomegalovirus induces CXCL10 and is restricted by adoptive transfer of splenocytes. J. Neurovirol. 10:152-162.
49. Cheeran, M. C., G. Gekker, S. Hu, J. M. Palmquist, and J. R. Lokensgard. 2005. T cell-mediated restriction of intracerebral murine cytomegalovirus infection displays dependence upon perforin but not interferon-gamma. J. Neurovirol. 11:274-280.
50. Cheeran, M. C., S. Hu, G. Gekker, and J. R. Lokensgard. 2000. Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes. J. Immunol. 164:926-933.
51. Cheeran, M. C., S. Hu, H. T. Ni, W. Sheng, J. M. Palmquist, P. K. Peterson, and J. R. Lokensgard. 2005. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J. Neurosci. Res. 82:839-850.
52. Cheeran, M. C., S, Hu, J. M. Palmquist, T. Bakken, G. Gekker, and J. R. Lokensgard. 2007. Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. Virus Res. 130:96-102.
53. Cheeran, M. C., S. Hu, W. S. Sheng, P. K. Peterson, and J. R. Lokensgard. 2003. CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J. Virol. 77:4502-4515.
54. Cheeran, M. C., S. Hu, S. L. Yager, G. Gekker, P. K. Peterson, and J. R. Lokensgard. 2001. Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J. Neurovirol. 7:135-147.
55. Chiou, S. H., J. H. Liu, W. M. Hsu, S. S. Chen, S. Y. Chang, L. J. Juan, J. C. Lin, Y. T. Yang, W. W. Wong, C. Y. Liu, Y. S. Lin, W. T. Liu, and C. W. Wu. 2001. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirus-induced apoptosis in human retina. J. Immunol. 167:4098-4103.
56. Chiou, S. H-, Y. P. Yang, J. C. Lin, C. H. Hsu, H. C. Jhang, Y. T. Yang, C. H. Lee, L. L. Ho, W. M. Hsu, H. H. Ku, S. J. Chen, S. S. Chen, M. D. Chang, C. W. Wu, and L. J. Juan. 2006. The immediate early 2 protein of human cytomegalovirus (HCMV) mediates the apoptotic control in HCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression. J. Immunol. 177:6199-6206.
57. Choi, C., and E. N. Benveniste. 2004. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res. Brain Res. Rev. 44:65-81.
58. Chou, S., N. S. Lurain, K. D. Thompson, R. C. Miner, and W. L. Drew. 2003. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J. Infect. Dis. 188:32-39.
59. Cinatl, J., Jr., R. Blaheta, M. Bittoova, M. Scholz, S. Margraf, J. U. Vogel, J. Cinatl, and H. W. Doerr. 2000. Decreased neutrophil adhesion to human cytomegalovims-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis. J. Immunol. 165:4405-4413.
60. Crowley, B. 2002. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection. J. Antimicrob. Chemother. 50:435-436.
61. Dahle, A. J., K. B. Fowler, J. D. Wright, S. B. Boppana, W. J. Britt, and R F. Pass. 2000. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11:283-290.
62. Davis, L. E., L. G. Johnsson, and M. Kornfeld. 1981. Cytomegalovirus labyrinthitis in an infant: morphological, virological, and immunofluores-cent studies. J. Neuropathol. Exp. Neurol. 40:9-19.
63. Davison, A. J., A. Dolan, P. Akter, C. Addison, D. J. Dargan, D. J. Alcendor, D. J. McGeoch, and G. S. Hayward. 2003. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol. 84:17-28.
64. DeBiasi, R. L., B. K. Kleins chmidt-DeMasters, S. Richards on-Burns, and K. L. Tyler. 2002. Central nervous system apoptosis in human herpes simplex virus and cytomegalovirus encephalitis. J. Infect. Dis. 186:1547-1557.
65. de Graaf-Peters, V. B., and M. Hadders-Algra. 2006. Ontogeny of the human central nervous system: what is happening when? Early Hum. Dev. 82:257-266.
66. Demmler, G. J. 1994. Congenital cytomegalovirus infection. Semin. Pediatr. Neurol. 1:36-42.
67. D'Erchia, A. M., C. Gissi, G. Pesole, C. Saccone, and U. Arnason. 1996. The guinea-pig is not a rodent. Nature 381:597-600.
68. Deshpande, M., J. Zheng, K. Borgmann, R. Persidsky, L. Wu, C. Schellpeper, and A, Ghorpade. 2005. Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotox. Res. 7:183-192.
69. Donnelly, T. M., and C. J. Brown. 2004. Guinea pig and chinchilla care and husbandry. Vet. Clin. N. Am. Exot. Anim. Pract. 7:351-373.
70. Edington, N., S. Broad, A. E. Wrathall, and J. T. Done. 1988. Superinfection with porcine cytomegalovirus initiating transplacental infection. Vet. Microbiol. 16:189-193.
71. Eggers, M., K. Radsak, G. Enders, and M. Reschke. 2001. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy. J. Med. Virol. 63:135-142.
72. Elbou Ould, M. A., D. Luton, M. Yadini, B. Pedron, Y. Aujard, E. Jacqz-Aigrain, F. Jacquemard, and G. Sterkers. 2004. Cellular immune response of fetuses to cytomegalovirus. Pediatr. Res. 55:280-286.
73. Eudy, J. D., M. D. Weston, S. Yao, D. M. Hoover, H. L. Rehm, M. Ma-Edmonds, D. Yan, I. Ahmad, J. J. Cheng, C. Ayuso, C. Cremers, S. Davenport, C. Moller, C. B. Talmadge, K. W. Beisel, M. Tamayo, C. C. Morton, A, Swaroop, W. J. Kimberling, and J. Sumegi. 1998. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 280:1753-1757.
74. Fagerheim, T., O. Nilssen, P. Raeymaekers, V. Brox, T. Mourn, H. H. Elverland, E. Teig, H. H. Omland, G. K. Fostad, and L. Tranebjaerg. 1996. Identification of a new locus for autosomal dominant non-syndromic hearing impairment (DFNA7) in a large Norwegian family. Hum. Mol. Genet. 5:1187-1191.
75. Fan-Havard, P., M. C. Nahata, and M. T. Brady. 1989. Ganciclovir - a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections. J. Clin. Pharm. Ther. 14: 329-340.
76. Fischler, B., T. H. Casswall, P. Malmborg, and A. Nemeth. 2002. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J. Pediatr. Gastroenterol. Nutr. 34:154-157.
77. Fish, K. N., C. Soderberg-Naucler, L. K. Mills, S. Stenglein, and J. A. Nelson. 1998. Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 72:5661-5668.
78. Fisher, S., O. Genbacev, E. Maidji, and L. Pereira. 2000. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J. Virol. 74:6808-6820.
79. Fleisher, G. R., S. E. Starr, H. M. Friedman, and S. A Plotkin. 1982. Vaccination of pediatric nurses with live attenuated cytomegalovirus. Am. J. Dis. Child. 136:294-296.
80. Fortunato, E. A., M. L. Dell'Aquila, and D. H. Spector. 2000. Specific chromosome 1 breaks induced by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 97:853-858.
81. Fowler, K. B., A. J. Dahle, S. B. Boppana, and R. F. Pass. 1999. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J. Pediatr. 135:60-64.
82. Fowler, K. B., F. P. McCollister, A. J. Dahle, S. Boppana, W. J. Britt, and R. F. Pass. 1997. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J. Pediatr. 130:624-630.
83. Fowler, K. B., and R. F. Pass. 2006. Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics 118:e286-e292.
84. Fowler, K. B., S. Stagno, and R. F. Pass. 1993. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J. Infect. Dis. 168:552-556.
85. Fowler, K. B., S. Stagno, and R. F. Pass. 2003. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA. 289:1008-1011.
86. Frey, S. E., C. Harrison, R. F. Pass, E. Yang, D. Boken, R. E. Sekulovich, S. Percell, A. E. Izu, S. Hirabayashi, R L. Burke, and A. M. Duliege. 1999. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine. J. Infect. Dis. 180: 1700-1703.
87. Fryer, J. F., P. D. Griffiths, V. C. Emery, and D. A. Clark. 2004. Susceptibility of porcine cytomegalovirus to antiviral drugs. J. Antimicrob. Chemother. 53:975-980.
88. Fukuda, S., E. M. Keithley, and J. P. Harris. 1988. Experimental cytomegalovirus infection: viremic spread to the inner ear. Am. J. Otolaryngol. 9:135-141.
89. Gage, F. H. 2000. Mammalian neural stem cells. Science 287:1433-1438.
90. Galea, I., I. Bechmann, and V. H. Perry. 2007. What is immune privilege (not)? Trends Immunol. 28:12-18.
91. Gaytant, M. A., E. A. Steegers, B. A. Semmekrot, H. M. Merkus, and J. M. Galama. 2002. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet. Gynecol. Surv. 57:245-256.
92. Gehrz, R. C., W. R. Christianson, K. M. Linner, K. E. Groth, and H. H. Balfour, Jr. 1980. Cytomegalovirus vaccine. Specific humoral and cellular immune responses in human volunteers. Arch. Intern. Med. 140:936-939.
93. Gerna, G., E. Percivalle, D. Lilleri, L. Lozza, C. Fornara, G. Hahn, F. Baldanti, and M. G. Revello. 2005. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J. Gen. Virol. 86:275-284.
94. Gibson, L., S. Dooley, S. Trzmielina, M. Somasundaran, D. Fisher, M. G. Revello, and K. Luzuriaga. 2007. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J. Infect. Dis. 195:1789-1798.
95. Gibson, L., G. Piccinini, D. Lilleri, M. G. Revello, Z. Wang, S. Markel, D. J. Diamond, and K. Luzuriaga. 2004. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J. Immunol. 172:2256-2264.
96. Goldmacher, V. S. 2005. Cell death suppression by cytomegaloviruses. Apoptosis 10:251-265.
97. Goldmacher, V. S., L. M. Bartle, A. Skaletskaya, C. A. Dionne, N. L. Kedersha, C. A. Vater, J. W. Han, R. J. Lutz, S. Watanabe, E. D. Cahir McFarland, E. D. Kieff, E. S. Mocarski, and T. Chittenden. 1999. A cyto-megalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA 96:12536- 12541.
98. Gonczol, E., P. W. Andrews, and S. A. Plotkin. 1984. Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science 224:159-161.
99. Gonczol, E., J. Ianacone, G. Furlini, W. Ho, and S. A. Plotkin. 1989. Humoral immune response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain. J. Infect. Dis. 159:851-859.
100. Grassi, M. P., F. Clerici, C. Perin, A. D'Arminio Monforte, L. Vago, M. Borella, R. Boldorini, and A. Mangoni. 1998. Microglial nodular encephalitis and ventriculoencephalitis due to cytomegalovirus infection in patients with AIDS: two distinct clinical patterns. Clin. Infect. Dis. 27:504-508.
101. Griffith, B. P., H. L. Lucia, and G. D. Hsiung. 1982. Brain and visceral involvement during congenital cytomegalovirus infection of guinea pigs. Pediatr. Res. 16:455-459.
102. Griffiths, P, D. 2002. The treatment of cytomegalovirus infection. J. Anti-microb. Chemother. 49:243-253.
103. Griffiths, P. D., A. McLean, and V. C. Emery. 2001. Encouraging prospects for immunisation against primaiy cvtomegalovirus infection. Vaccine 19: 1356-1362.
104. Haginoya, K., T. Ohura, K. Kon, T. Yagi, Y. Sawaishi, K, K. Ishii, T. Funato, S. Higano, S. Takahashi, and K. Iinuma. 2002. Abnormal white matter lesions with sensorineural hearing loss caused by congenital cytomegalovirus infection: retrospective diagnosis by PCR using Guthrie cards. Brain Dev. 24:710-714.
105. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95:3937-3942.
106. Hahn, G., M. G. Revello, M. Patrone, E. Percivalle, G. Campanini, A. Sarasini, M. Wagner, A. Galium, G. Milanesi, U. Koszinowski, F. Baldanti, and G. Gerna. 2004. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 78:10023-10033.
107. Halwachs-Baumann, G. 2006. The congenital cytomegalovirus infection: virus-host interaction for defense and transmission. Curr. Pharm. Biotechnol. 7:303-312.
108. Han, G. P., L. Li, L Kosugi, H. Kawasaki, T. Tsuchida, K. Miura, and Y. Tsutsui. 2007. Enhancement of susceptibility of adult mouse brain to cytomegalovirus infection by infusion of epidermal growth factor. J. Neurosci. Res. 85:2981-2990.
109. Harris, J. P., N. K. Woolf, A. F. Ryan, D. M. Butler, and D. D. Richman. 1984. Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig. J. Infect. Dis. 150:523-530.
110. Harrison, C. J., W. J. Britt, N. M. Chapman, J. Mullican, and S. Tracy. 1995. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model. J. Infect. Dis. 172:1212-1220.
111. Hartley, J. W., W. P. Rowe, and R. J. Huebner. 1957. Serial propagation of the guinea pig salivary gland virus in tissue culture. Proc. Soc. Exp. Biol. Med. 96:281-285.
112. Hassan, J., S. Dooley, and W. Hall. 2007. Immunological response to cytomegalovirus in congenitally infected neonates. Clin. Exp. Immunol. 147:465-471.
113. Heineman, T. C., M. Schleiss, D. I. Bernstein, R. R. Spaete, L. Yan, G. Duke, M. Prichard, Z. Wang, Q. Yan, M. A. Sharp, N. Klein, A. M. Arvin, and G. Kemble. 2006. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. J. Infect. Dis. 193:1350-1360.
114. Hertel, L., S. Chou, and E. S. Mocarski. 2007. Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog. 3:e6.
115. Hicks, T., K. Fowler, M. Richardson, A. Dahle, L. Adams, and R. Pass. 1993. Congenital cytomegalovirus infection and neonatal auditory screening. J. Pediatr. 123:779-782.
116. Ho, W. S., and A. N. van den Pol. 2007. Bystander attenuation of neuronal and astrocyte intercellular communication by murine cytomegalovirus infection of glia. J. Virol. 81:7286-7292.
117. Hocker, J. R., L. N. Cook, G. Adams, and G. P. Rabalais. 1990. Ganciclovir therapy of congenital cytomegalovirus pneumonia. Pediatr. Infect. Dis. J. 9:743-745.
118. Holt, P. G., and C. A. Jones. 2000. The development of the immune system during pregnancy and early life. Allergy 55:688-697.
119. Huang, D., Y. Han, M. R. Rani, A. Glabinski, C. Trebst, T. Sorensen, M. Tani, J. Wang, P. Chien, S. O'Bryan, B. Bielecki, Z. L. Zhou, S. Majumder, and R. M. Ransohoff. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol. Rev. 177:52-67.
120. Ishiwata, M., S. Baba, M. Kawashima, I. Kosugi, H. Kawasaki, M. Kaneta, T. Tsuchida, S. Kozuma, and Y. Tsutsui. 2006. Differential expression of the immediate-early 2 and 3 proteins in developing mouse brains infected with murine cytomegalovirus. Arch. Virol. 151:2181-2196.
121. Jamieson, D. J., J. E. Ellis, D. B. Jernigan, and T. A. Treadwell. 2006. Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists. Am. J. Obstet. Gynecol. 194:1546-1555.
122. Jarvis, M. A., and J. A. Nelson. 2002. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr. Opin. Microbiol. 5:403-407.
123. Jault, F. M., J. M. Jault, F. Ruchti, E. A. Fortunato, C. Clark, J. Corbeil, D. D. Richman, and D. H. Spector. 1995. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69:6697-6704.
124. Junker, A. K., D. Matheson, A. J. Tingle, and E. E. Thomas. 1991. Immune responses after ganciclovir and immunoglobulin therapy of infants. Pediatr. Infect. Dis. J. 10:256-258.
125. Kashiwai, A., N. Kawamura, C. Kadota, and Y. Tsutsui, 1992. Susceptibility of mouse embryo to murine cytomegalovirus infection in early and mid-gestation stages. Arch. Virol. 127:37-48.
126. Katano, H., Y. Sato, Y. Tsutsui, T. Sata, A. Maeda, N. Nozawa, N. Inoue, Y. Nomura, and T. Kurata. 2007. Pathogenesis of cytomegalovirus- associated labyrinthitis in a guinea pig model. Microbes Infect. 9:183-191.
127. Kaufmann, P., and M. Davidoff. 1977. The guinea-pig placenta. Adv. Anat. Embryol. Cell Biol. 53:5-91.
128. Kawasaki, H., I. Kosugi, Y. Arai, and Y. Tsutsui. 2002. The amount of immature glial cells in organotypic brain slices determines the susceptibility to murine cytomegalovirus infection. Lab Investig. 82:1347-1358.
129. Keithley, E. M., N. K. Woolf, and J. P. Harris. 1989. Development of morphological and physiological changes in the cochlea induced by cytomegalovirus. Laryngoscope 99:409-414.
130. Keller, M. J., A. W. Wu, J. I. Andrews, P. W. McGonagill, E. E. Tibesar, and J. L. Meier. 2007. Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway. J. Virol. 81:6669-6681.
131. Kemble, G., G. Duke, R. Winter, and R. Spaete. 1996. Defined large-scale alterations of the human cytomegalovirus genome constructed by cotrans-fection of overlapping cosmids. J. Virol. 70:2044-2048.
132. Kenneson, A., and M. J. Cannon. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17:253-276.
133. Kimberlin, D. W. 2002. Antiviral therapy for cytomegalovirus infections in pediatric patients. Semin. Pediatr. Infect. Dis. 13:22-30.
134. Kimberlin, D. W., C. Y. Lin, P. J. Sanchez, G. J. Demmler, W. Dankner, M. Shelton, R. F. Jacobs, W. Vaudry, R. F. Pass, J. M. Kiell, S. J. Soong, and R. J. Whitley. 2003. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 143:16-25.
135. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91:11879-11883.
136. Kondo, K., J. Xu, and E. S. Mocarski. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA 93:11137-11142.
137. Koontz, T., M. Bralic, J. Tomac, E. Pernjak-Pugel, G. Bantug, S. Jonjic, and W. J. Britt. 2008. Altered development of the brain after focal herpesvirus infection of the central nervous system. J. Exp. Med. 205:423-435.
138. Kossmann, T., M. C. Morganti-Kossmann, J. M. Orenstein, W. J. Britt, S. M. Wahl, and P. D. Smith. 2003. Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-beta release. J. Infect. Dis. 187:534-541.
139. Kosugi, L, H. Kawasaki, Y. Arai, and Y. Tsutsui. 2002. Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. Am. J. Pathol. 161:919-928.
140. Kosugi, I., H. Kawasaki, T. Tsuchida, and Y. Tsutsui. 2005. Cytomegalovirus infection inhibits the expression of N-methyl-D- aspartate receptors in the developing mouse hippocampus and primary neuronal cultures. Acta Neuropathol. 109:475-482.
141. Kosugi, I., Y. Shinmura, R. Y. Li, S. Aiba-Masago, S. Baba, K. Miura, and Y. Tsutsui. 1998. Murine cytomegalovirus induces apoptosis in non-infected cells of the developing mouse brain and blocks apoptosis in primary neuronal culture. Acta Neuropathol. 96:239-247.
142. Kylat, R. I., E. N. Kelly, and E. L. Ford-Jones. 2006. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur. J. Pediatr. 165:773-778.
143. LaFemina, R., and G. S. Hayward. 1986. Constitutive and retinoic acid-inducible expression of cytomegalovirus immediate-early genes in human teratocarcinoma cells. J. Virol. 58:434-440.
144. La Rosa, C., Z. Wang, S. F. Lacey, S. F. Markel, M. C. Sharma, J. Martinez, M. M. Lalimarmo, and D. J. Diamond. 2005. Characterization of host immunity to cytomegalovirus pp150 (UL32). Hum. Immunol. 66:116-126.
145. Lathey, J. L., and S. A. Spector. 1991. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65:6371-6375.
146. Lathey, J. L., C. A. Wiley, M. A. Verity, and J. A. Nelson. 1990. Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus. Virology 176:266-273.
147. La Torre, R., G. Nigro, M. Mazzocco, A. M. Best, and S. P. Adler. 2006. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin. Infect. Dis. 43:994-1000.
148. Lazzarotto, T., P. Spezzacatena, P. Pradelli, D. A. Abate, S. Varani, and M. P. Landini. 1997. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin. Diagn. Lab. Immunol. 4:469-473.
149. Lazzarotto, T., S. Varani, B. Guerra, A. Nicolosi, M. Lanari, and M. P. Landini. 2000. Prenatal indicators of congenital cytomegalovirus infection. J. Pediatr. 137:90-95.
150. Leiser, R., and P. Kaufmann. 1994. Placental structure: in a comparative aspect. Exp. Clin. Endocrinol. 102:122-134.
151. Li, R. Y., and Y. Tsutsui. 2000. Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus. Teratology 62:79-85.
152. Lim, K. H., Y. Zhou, M. Janatpour, M. McMaster, K. Bass, S. H. Chun, and S. J. Fisher. 1997. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am. J. Pathol. 151:1809-1818.
153. Littler, E., A. D. Stuart, and M. S. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
154. Lockridge, K. M., G. Sequar, S. S. Zhou, Y. Yue, C. P. Mandell, and P. A. Barry. 1999. Pathogenesis of experimental rhesus cytomegalovirus infection. J. Virol. 73:9576-9583.
155. Loh, H, S., M. L. Mohd-Azmi, K. Y. Lai, A. R. Sheikh-Omar, and M. Zamri-Saad. 2003. Characterization of a novel rat cytomegalovirus (RCMV) infecting placenta-uterus of Rattus rattus diardii. Arch. Virol. 148:2353-2367.
156. Loh, H. S., M. A. Mohd-Lila, S. O. Abdul-Rahman, and L. J. Kiew. 2006. Pathogenesis and vertical transmission of a transplacental rat cytomegalovirus. Virol. J. 3:42.
157. Lokensgard, J. R., M. C. Cheeran, G. Gekker, S. Hu, C. C. Chao, and P. K. Peterson. 1999. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J. Hum. Virol. 2:91-101.
158. Lokensgard, J. R., M. C. Cheeran, S. Hu, G. Gekker, and P. K. Peterson. 2002. Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J. Infect. Dis. 186(Suppl. 2):S171-S179.
159. 1 to S. J. Virol. 70:8850-8857.
160. Ma, D. K., G. L. Ming, and H. Song. 2005. Glial influences on neural stem cell development: cellular niches for adult neurogenesis. Curr. Opin. Neu-robiol. 15:514-520.
161. Maidji, E., S. McDonagh, O. Genbacev, T. Tabata, and L. Pereira. 2006. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am. J. Pathol. 168:1210-1226.
162. Malinger, G., D. Lev, N. Zahalka, Z. Ben Aroia, N. Watemberg, D. Kidron, L. B. Sira, and T. Lerman-Sagie. 2003. Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am. J. Neuroradiol. 24:28-32.
163. Manning, W. C., and E. S. Mocarski. 1988. lnsertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology 167:477-484.
164. Marchant, A., V. Appay, M. Van Der Sande, N. Dulphy, C. Liesnard, M. Kidd, S. Kaye, O. Ojuola, G. M. Gillespie, A. L. Vargas Cuero, V. Cerundolo, M. Callan, K. P. McAdam, S. L. Rowland-Jones, C. Donner, A. J. McMichael, and H. Whittle. 2003. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J. Clin. Investig. 111:1747-1755.
165. Martinez-Cerdeno, V., S. C. Noctor, and A. R. Kriegstein. 2006. The role of intermediate progenitor cells in the evolutionary expansion of the cerebral cortex. Cereb. Cortex 16(Suppl. 1):i152-i161.
166. Matsukage, S., I. Kosugi, H. Kawasaski, K. Miura, H. Kitani, and Y. Tsutsui. 2006. Mouse embryonic stem cells are not susceptible to cytomegalovirus but acquire susceptibility during differentiation. Birth Defects Res. A 76:115-125.
167. McCarthy, M., D. Auger, and S. R. Whittemore. 2000. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J. Hum. Virol. 3:215-228.
168. McCarthy, M., C. Wood, L. Fedoseyeva, and S. R. Whittemore. 1995. Media components influence viral gene expression assays in human fetal astrocyte cultures. J. Neurovirol. 1:275-285.
169. McCluskey, R., R. Sandin, and J. Greene. 1996. Detection of airborne cvtomegalovirus in hospital rooms of immunocompromised patients. J. Virol. Methods 56:115-118.
170. McCormick, A. L., A. Skaletskaya, P. A. Barry, E. S. Mocarski, and V. S. Goldmacher. 2003. Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 316:221-233.
171. McCormick, A. L., V. L. Smith, D. Chow, and E. S. Mocarski. 2003. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J. Virol. 77:631-641.
172. Meier, J. L. 2001. Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. J. Virol. 75:1581-1593.
173. Meier, J. L., and J. A. Pruessner. 2000. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J. Virol. 74:1602-1613.
174. Merkle, F. T., and A, Alvarez-Buylla. 2006. Neural stem cells in mammalian development. Curr. Opin. Cell Biol. 18:704-709.
175. Michaels, M. G., D. P. Greenberg, D. L. Sabo, and E. R. Wald. 2003. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr. Infect. Dis. J. 22:504-509.
176. Mitchell, D. K., S. J. Holmes, R. L. Burke, A. M. Duliege, and S. P. Adler. 2002. Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers. Pediatr. Infect. Dis. J. 21:133-138.
177. Moore, M. A. 2004. The role of cell migration in the ontogeny of the lymphoid system. Stem Cells Dev. 13:1-21.
178. Muganda, P., O. Mendoza, J. Hernandez, and Q. Qian. 1994. Human cvtomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts. J. Virol. 68:8028-8034.
179. Neff, B. J., R. E. Weibel, E. B. Buynak, A. A. McLean, and M. R. Hilleman. 1979. Clinical and laboratory studies of live cytomegalovirus vaccine Ad-169. Proc. Soc. Exp. Biol. Med. 160:32-37.
180. Nelson, C. T., and G. J. Demmler. 1997. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin. Perinatol. 24:151-160.
181. Nguyen, M. D., J. P. Julien, and S. Rivest. 2002. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neuro-sci. 3:216-227.
182. Ni, H. T., S. Hu, W. S. Sheng, J. M. Olson, M. C. Cheeran, A. S. Chan, J. R. Lokensgard, and P. K. Peterson. 2004. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res. Dev. Brain Res. 152:159-169.
183. Niederkorn, J. Y. 2006. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7:354-359.
184. Nigro, G., S. P. Adler, R. La Torre, and A. M. Best. 2005. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 353:1350-1362.
185. Nigro, G., A. Krzysztoftak, U. Bartmann, A. Clerico, E. Properzi, S. Valia, and M. Castello. 1997. Ganciclovir therapy for cytomegalovirus- associated liver disease in immunocompetent or immunocompromised children. Arch. Virol. 142:573-580.
186. Nigro, G., H. Scholz, and U. Bartmann. 1994. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J. Pediatr. 124:318-322.
187. Noonan, D. 1994. The guinea pig (Cavia porcellus). ANZCCART News 7:1-8.
188. Noyola, D. E., G. J. Demmler, C. T. Nelson, C. Griesser, W. D. Williamson, J. T. Atkins, J. Rozelle, M. Turcich, A. M. Llorente, S. Sellers-Vinson, A. Reynolds, J. F. Bale, Jr., P. Gerson, and M. D. Yow. 2001. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J. Pediatr. 138:325-331.
189. Noyola, D. E., G. J. Demmler, W. D. Williamson, C. Griesser, S. Sellers, A. Llorente, T. Littman, S. Williams, L. Jarrett, M. D. Yow, et al. 2000. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Pediatr. Infect. Dis. J. 19:505-510.
190. Odeberg, J., N. Wolmer, S. Falci, M. Westgren, A. Seiger, and C. Soderberg-Naucler. 2006. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 80: 8929-8939.
191. Odeberg, J., N. Wolmer, S. Falci, M. Westgren, E. Sundtrom, A. Seiger, and C. Soderberg-Naucler. 2007. Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes. J. Neurosci. Res. 85:583-593.
192. Ogawa, H., T. Suzutani, Y. Baba, S. Koyano, N. Nozawa, K. Ishibashi, K. Fujieda, N. Inoue, and K. Omori. 2007. Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J. Infect. Dis. 195:782-788.
193. Ornoy, A., and O. Diav-Citrin. 2006. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod. Toxicol. 21:399-409.
194. Ossipow, V., P. Descombes, and U.Schibler. 1993. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA 90:8219-8223.
195. Pachter, J. S., H. E. de Vries, and Z. Fabry. 2003. The blood-brain barrier and its role in immune privilege in the central nervous system. J. Neuro-pathol. Exp. Neurol. 62:593-604.
196. Pass, R. F. 2005. Congenital cytomegalovirus infection and hearing loss. Herpes 12:50-55.
197. Pass, R. F., A. M. Duliege, S. Boppana, R. Sekulovich, S. Percell, W. Britt, and R. L. Burke. 1999. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J. Infect. Dis. 180:970-975.
198. Pass, R. F., K. B. Fowler, S. B. Boppana, W. J. Britt, and S. Stagno. 2006. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 35:216-220.
199. Pereira, L., E. Maidji, S. McDonagh, O. Genbacev, and S. Fisher. 2003. Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J. Virol. 77:13301-13314.
200. Pereira, L., E. Maidji, S. McDonagh, and T. Tabata. 2005. Insights into viral transmission at the uterine-placental interface. Trends Microbiol. 13: 164-174.
201. Perlman, J. M., and C. Argyle. 1992. Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann. Neurol. 31:64-68.
202. Petrik, D. T., K. P. Schmitt, and M. F. Stinski. 2006. Inhibition of cellular DNA synthesis by the human cytomegalovirus IE86 protein is necessary for efficient virus replication. J. Virol. 80:3872-3883.
203. Plotkin, S. A., R. Higgins, J. B. Kurtz, P. J. Morris, D. A. Campbell, Jr., T. C. Shope, S. A. Spector, and W. M. Dankner. 1994. Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation 58:1176-1178.
204. Plotkin, S. A., S. E. Starr, H. M. Friedman, K. Brayman, S. Harris, S. Jackson, N. B. Tustin, R. Grossman, D. Dafoe, and C. Barker. 1991. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann. Intern. Med. 114:525-531.
205. Plotkin, S. A., S. E. Starr, H. M. Friedman, E. Gonczol, and R E. Weibel. 1989. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J. Infect. Dis. 159: 860-865.
206. Plotkin, S. A., and H. Stetler. 1969. Treatment of congenital cytomegalic inclusion disease with antiviral agents. Antimicrob. Agents Chemother. 9:372-379.
207. Poland, S. D., L. L. Bambrick, G. A. Dekaban, and G. P. Rice. 1994. The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation. J. Infect. Dis. 170:1267-1271.
208. Poland, S. D., P. Costello, G. A. Dekaban, and G. P. Rice. 1990. Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J. Infect. Dis. 162:1252-1262.
209. Poncet, D., N. Larochette, A. L. Pauleau, P. Boya, A. A. Jalil, P. F. Cartron, F. Vallette, C. Schnebelen, L. M. Bartle, A. Skaletskaya, D. Boutolleau, J. C. Martinou, V. S. Goldmacher, G. Kroemer, and N. Zamzami. 2004. An anti-apoptotic viral protein that recruits Bax to mitochondria. J. Biol. Chem. 279:22605-22614.
210. Poncet, D., A. L. Pauleau, G. Szabadkai, A. Vozza, S. R. Scholz, M. Le Bras, J. J. Briere, A. Jalil, R, Le Moigne, C. Brenner, G. Hahn, I. Wittig, H. Schagger, C. Lemaire, K. Bianchi, S. Souquere, G. Pierron, P. Rustin, V. S. Goldmacher, R. Rizzuto, F. Palmieri, and G. Kroemer. 2006. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J. Cell Biol. 174:985-996.
211. Prosch, S., A. K. Heine, H. D. Volk, and D. H. Kruger. 2001. CCAAT/ enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J. Biol. Chem. 276:40712-40720.
212. Pulliam, L. 1991. Cytomegalovirus preferentially infects a monocyte derived macrophage/microglial cell in human brain cultures: neuropathology differs between strains. J. Neuropathol. Exp. Neurol. 50:432-440.
213. Pulliam, L., D. Moore, and D. C. West. 1995. Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: possible role in neurotoxicity. J. Neurovirol. 1:219-227.
214. Quesenberry, K. E. 1994. Guinea pigs. Vet. Clin. N. Am. Small Anim. Tract. 24:67-87.
215. Quinnan, G. V., Jr., M. Delery, A. H. Rook, W. R. Frederick, J. S. Epstein, J. F. Manischewitz, L. Jackson, K. M. Ramsey, K. Mittal, S. A. Plotkin, and et al. 1984. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann. Intern. Med. 101:478-483.
216. Raftery, M. J., M. Schwab, S. M. Eibert, Y. Samstag, H. Walczak, and G. Schonrich. 2001. Targeting the function of mature dendritic cells by human cvtomegalovirus: a multilayered viral defense strategy. Immunity 15:997-1009.
217. Rarey, K. E., and L. E. Davis. 1993. Temporal bone histopathology 14 years after cytomegalic inclusion disease: a case study. Laryngoscope 103:904-909.
218. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
219. Reboredo, M., R. F. Greaves, and G. Hahn. 2004. Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J. Gen. Virol. 85:3555-3567.
220. Reigstad, H., R. Bjerknes, T. Markestad, and H. Myrmel. 1992. Ganciclovir therapy of congenital cytomegalovirus disease. Acta Paediatr. 81:707-708.
221. Renter, J. D., D. L. Gomez, J. H. Wilson, and A. N. Van Den Pol. 2004. Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain. J. Virol. 78:1473-1487.
222. Revello, M. G., M. Zavattoni, M. Furione, E. Fabbri, and G. Gerna. 2006. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J. Infect. Dis. 193:783-787.
223. Rock, R B., G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson. 2004. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 17:942-964.
224. Ross, D. S., S. C. Dollard, M. Victor, E. Sumartojo, and M. J. Cannon. 2006. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J. Womens Health (Larchmt.) 15:224-229.
225. Ross, S. A., and S. B. Boppana. 2005. Congenital cytomegalovirus infection: outcome and diagnosis. Semin. Pediatr. Infect. Dis. 16:44-49.
226. Ross, S. A., K, B. Fowler, G. Ashrith, S. Stagno, W, J. Britt, R F. Pass, and S. B. Boppana. 2006. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J. Pediatr. 148: 332-336.
227. Sachs, G. W., R. L. Simmons, and H. H. Balfour, Jr. 1984. Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates. Vaccine 2:215-218.
228. Schleiss, M. R. 2002. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cvtomegalovirus (GPCMV). J. Clin. Virol. 25(Suppl. 2):S37-S49.
229. Schleiss, M. R. 2006. The role of the placenta in the pathogenesis of congenital cytomegalovirus infection: is the benefit of cytomegalovirus immune globulin for the newborn mediated through improved placental health and function? Clin. Infect. Dis. 43:1001-1003.
230. Schleiss, M. R., B. J. Aronow, and S. Handwerger. 2007. Cytomegalovirus infection of human syncytiotrophoblast cells strongly interferes with expression of genes involved in placental differentiation and tissue integrity. Pediatr. Res. 61:565-571.
231. Schleiss, M. R., N. Bourne, and D. I. Bernstein. 2003. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J. Infect. Dis. 188:1868-1874.
232. Schleiss, M. R., N. Bourne, N. J. Jensen, F. Bravo, and D. I. Bernstein. 2000. Immunogenicity evaluation of DNA vaccines that target guinea pig cvtomegalovirus proteins glvcoprotein B and UL83. Viral Immunol. 13: 155-167.
233. Schleiss, M. R., N. Bourne, G. Stroup, F. J. Bravo, N. J. Jensen, and D. I. Bernstein. 2004. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J. Infect. Dis. 189:1374-1381.
234. Schleiss, M. R., and T. C. Heineman. 2005. Progress toward an elusive goal: current status of cytomegalovirus vaccines. Expert Rev. Vaccines 4:381-406.
235. Schleiss, M. R., J. C. Lacayo, Y. Belkaid, A. McGregor, G. Stroup, J. Rayner, K. Alterson, J. D. Chulay, and J. F. Smith. 2007. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J. Infect. Dis. 195:789-798.
236. Schmidbauer, M., H. Budka, W. Ulrich, and P. Ambros. 1989. Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization. Acta Neuropathol. (Berlin).79:286-293.
237. Sehraff, S. A., D. K. Brown, M. R. Schleiss, J. Meinzen-Derr, J. H. Grein-wald, and D. I. Choo. 2007. The role of CMV inflammatory genes in hearing loss. Otol. Neurotol. 28:964-969.
238. Schupfer, P. C., J. R. Murph, and J. F. Bale, Jr. 1986. Survival of cytomegalovirus in paper diapers and saliva. Pediatr. Infect. Dis. 5:677-679.
239. Schut, R. L., G. Gekker, S. Hu, C. C. Chao, C. Pomeroy, M. C. Jordan, and P. K. Peterson. 1994. Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma. J. Infect. Dis. 169:1092-1096.
240. Selinsky, C., C., Luke, M. Wloch, A. Geall, G. Hermanson, D. Kaslow, and T. Evans. 2005. A DNA-based vaccine for the prevention of human cyto-megalovirus-associated diseases. Hum. Vaccines 1:16-23.
241. Shinmura, Y., L Kosugi, S. Aiba-Masago, S. Baba, L. R. Yong, and Y. Tsutsui. 1997. Disordered migration and loss of virus-infected neuronal cells in developing mouse brains infected with murine cytomegalovirus. Acta Neuropathol. 93:551-557.
242. Shinmura, Y., L Kosugi, M. Kaneta, and Y. Tsutsui. 1999. Migration of virus-infected neuronal cells in cerebral slice cultures of developing mouse brains after in vitro infection with murine cytomegalovirus. Acta Neuropathol. 98:590-596.
243. Simard, A, R., and S. Rivest. 2005. Do pathogen exposure and innate immunity cause brain diseases? Neurol. Res. 27:717-725.
244. Sinzger, C., K. Eberhardt, Y. Cavignac, C. Weinstock, T. Kessler, G. Jahn, and J. L. Davignon. 2006. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class 11 molecules. J. Gen. Virol. 87:1853-1862.
245. Sinzger, C., M. Kahl, K. Laib, K. Klingel, P. Rieger, B. Plachter, and G. Jahn. 2000. Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J. Gen. Virol. 81:3021-3035.
246. Skaletskaya, A., L. M. Bartle, T. Chittenden, A. L. McCormick, E. S. Mocarski, and V. S. Goldmacher. 2001. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA 98:7829-7834.
247. + monocytes is differentiation dependent. J. Virol. 75:7543-7554.
248. Sohn, Y. M., M. K. Oh, K. B. Balcarek, G. A. Cloud, and R. F. Pass. 1991. Cytomegalovirus infection in sexually active adolescents. J. Infect. Dis. 163:460-463.
249. Song, Y. J., and M. F. Stinski. 2002. Effect of the human cytomegalovirus 1E86 protein on expression of E2F-responsive genes: a DNA microarray analysis. Proc. Natl. Acad. Sci. USA 99:2836-2841.
250. Spaete, R. R. 1991. A recombinant subunit vaccine approach to HCMV vaccine development. Transplant. Proc. 23:90-96.
251. Spaete, R. R., R. M. Thayer, W. S. Probert, F. R. Masiarz, S. H. Chamberlain, L. Rasmussen, T. C. Merigan, and C. Pachl. 1988. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207-225.
252. Speir, E., R. Modali, E. S. Huang, M. B. Leon, F. Shawl, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
253. Spiller, O. B., L. K. Borysiewicz, and B. P. Morgan. 1997. Development of a model for cytomegalovirus infection of oligodendrocytes. J. Gen. Virol. 78:3349-3356.
254. Stagno, S., R. F. Pass, G. Cloud, W. J. Britt, R. E. Henderson, P. D. Walton, D. A. Yeren, F. Page, and C. A. Alford. 1986. Primary cytomegalovirus infection in pregnancv. Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904-1908.
255. Staras, S. A., S. C. Dollard, K. W. Radford, W. D. Flanders, R. F. Pass, and M. J. Cannon. 2006. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin. Infect. Dis. 43:1143-1151.
256. Staras, S. A., W. D. Flanders, S. C. Dollard, R. F. Pass, J. E. McGowan, Jr., and M. J. Cannon. 2008. Influence of sexual activity on cytomegalovirus seroprevalence in the United States. 1988-1994. Sex. Transm. Dis. 35:472-479.
257. Starr, S. E., J. P. Glazer, H. M. Friedman, J. D. Farquhar, and S. A. Plotkin. 1981. Specific cellular and humoral immunity after immunization with live Towne strain cytomegalovirus vaccine. J. Infect. Dis. 143:585-589.
258. Strauss, M. 1985. A clinical pathologic study of hearing loss in congenital cytomegalovirus infection. Laryngoscope 95:951-962.
259. Strauss, M. 1990. Human cytomegalovirus labyrinthitis. Am. J. Otolaryngol. 11:292-298.
260. Streblow, D. N., C. N. Kreklywich, P. Smith, J. L. Soule, C. Meyer, M. Yin, P. Beisser, C. Vink, J, A Nelson, and S. L, Orloff, 2005. Rat cytomegalo-virus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am. J. Transplant. 5:436-442.
261. Sugiura, S., T. Yoshikawa, Y. Nishiyama, Y. Morishita, E. Sato, T. Hattori, and T. Nakashima. 2003. Detection of human cytomegalovirus DNA in perilymph of patients with sensorineural hearing loss using real-time PCR. J. Med. Virol. 69:72-75.
262. Sullivan, V., C. L. Talarico, S. C. Stanat, M. Davis, D. M. Coen, and K. K. Biron. 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cvtomegalovirus-infected cells. Nature 358: 162-164.
263. Sumegi, J., J. Y. Wang, D. K. Zhen, J. D. Eudy, C. B. Talmadge, B. F. Li, P. Berglund, M. D. Weston, S. F. Yao, M. Ma-Edmonds, L. Overbeck, P. M. Kelley, E. Zabarovsky, E. Uzvolgyi, E. J. Stanbridge, G. Klein, and W. J. Kimberling. 1996. The construction of a yeast artificial chromosome (YAC) contig in the vicinity of the Usher syndrome type IIa (USH2A) gene in lq41. Genomics 35:79-86.
264. Tarantal, A. F., M. S. Salamat, W. J. Britt, P. A. Luciw, A. G. Hendrickx, and P. A Barry. 1998. Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J. Infect. Dis. 177:446-450.
265. Temperton, N. J. 2002. DNA vaccines against cytomegalovirus: current progress. Int. J. Antimicrob. Agents 19:169-172.
266. Temple, S. 2001. The development of neural stem cells. Nature 414:112-117.
267. Terhune, S., E. Torigoi, N. Moorman, M. Silva, Z. Qian, T. Shenk, and D. Yu. 2007. Human cytomegalovirus UL38 protein blocks apoptosis. J. Virol. 81:3109-3123.
268. Tsai, H. L., G. H. Kou, S. C. Chen, C. W. Wu, and Y. S. Lin. 1996. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J. Biol. Chem. 271:3534-3540.
269. Tsutsui, Y. 1995. Developmental disorders of the mouse brain induced by murine cytomegalovirus: animal models for congenital cytomegalovirus infection. Pathol. Int. 45:91-102.
270. Tsutsui, Y., A. Kashiwai, N. Kawamura, S. Aiba-Masago, and I. Kosugi. 1995. Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch. Virol. 140:1725-1736.
271. Tsutsui, Y., I. Kosugi, and H. Kawasaki. 2005. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev. Med. Virol. 15:327-345.
272. Vallejo, J. G., J. A Englund, J. A Gareia-Prats, and G. J. Demmler. 1994. Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate. Pediatr. Infect. Dis. J. 13:239-241.
273. van den Pol, A N., M. D. Robek, P. K. Ghosh, K. Ozduman, P. Bandi, M. D. Whim, and G. Wollmann. 2007. Cytomegalovirus induces interferon- stimulated gene expression and is attenuated by interferon in the developing brain. J. Virol. 81:332-348.
274. van der Knaap, M. S., G. Vermeulen, F. Barkhof, A. A. Hart, J. G. Loeber, and J. F. Weel. 2004. Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection. Radiology 230:529-536.
275. Van Hoosier, G. L., Jr., W. E. Giddens, Jr., C. S. Gillett, and H. Davis. 1985. Disseminated cytomegalovirus disease in the guinea pig. Lab. Anim. Sci. 35:81-84.
276. Verkhratsky, A., and F. Kirchhoff. 2007. NMDA receptors in glia. Neuro-scientist 13:28-37.
277. Vilalta, A., R. K. Mahajan, J. Hartikka, D. Rusalov, T. Martin, V. Bozo-ukova, V. Leamy, K. Hall, P. Lalor, A Rolland, and D. C. Kaslow. 2005. I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration. Hum. Gene Ther. 16:1143-1150.
278. Vink, C., E. Beuken, and C. A. Bruggeman. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:7656-7665.
279. Wang, Z., C. L. Rosa, Z. Li, H. Ly, A. Krishnan, J. Martinez, W. J. Britt, and D. J. Diamond. 2007. Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and 1E1. Vaccine 25:1132-1141.
280. Wangemann, P. 2002. K(+) cycling and its regulation in the cochlea and the vestibular labyrinth. Audiol. Neurootol. 7:199-205.
281. Wheeler, D. G., and E. Cooper. 2001. Depolarization strongly induces human cytomegalovirus major immediate-early promoter/enhancer activity in neurons. J. Biol. Chem. 276:31978-31985.
282. Wicher, K., V. Wicher, and R. F. Gruhn. 1985. Differences in susceptibility to infection with Treponema pallidum (Nichols) between five strains of guinea pig. Genitourin. Med. 61:21-26.
283. Williamson, W. D., A. K. Percy, M. D. Yow, P. Gerson, F. I. Catlin, M. L. Koppelman, and S. Thurber. 1990. Asymptomatic congenital cytomegalovirus infection. Audiologic, neuroradiologic, and neurode-velopmental abnormalities during the first vear. Am. J. Dis. Child. 144: 1365-1368.
284. Woolf, N. K., J. P. Harris, A F. Ryan, D. M. Butler, and D. D. Richman. 1985. Hearing loss in experimental cytomegalovirus infection of the guinea pig inner ear: prevention by systemic immunity. Ann. Otol. Rhinol. Laryn-gol. 94:350-356.
285. Woolf, N. K., D. V. Jaquish, and F. J, Koehrn. 2007. Transplacental murine cytomegalovirus infection in the brain of SC1D mice. Virol. J. 4:26.
286. Xia, X., Y. Zhang, C. R. Zieth, and S. C. Zhang. 2007. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 16:167-176.
287. Yamamoto-Tabata, T., S. McDonagh, H. T. Chang, S. Fisher, and L. Pereira. 2004. Human cytomegalovirus interleukin-10 downregulates metal-loproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J. Virol. 78:2831-2840.
288. Yue, Y., S. S. Zhou, and P. A. Barry. 2003. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques. J. Gen. Virol. 84:3371-3379.
289. Zhang, C., and R. F. Pass. 2004. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine. Vaccine 23:507-510.
290. Zhu, H., Y. Shen, and T. Shenk. 1995. Human cytomegalovirus 1E1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.